Oruka Therapeutics is a dynamic biopharmaceutical company dedicated to advancing the field of antibody-based therapies. With a focus on innovation and strategic development, the company aims to protect and enhance its intellectual property portfolio to support its research and commercialization objectives. Oruka Therapeutics fosters a collaborative environment where legal and scientific expertise converge to drive the company's mission forward, ensuring that its groundbreaking innovations are safeguarded in a competitive landscape.